Beta Bionics, Inc.
(NASDAQ: BBNX)

Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.

30.000

- (-%)
Range 28.760 - 30.925   (7.53%)
Open 30.410
Previous Close 30.000
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 634,913
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 04:08.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis